


Allink Biotherapeutics
Biotechnology Research • Shanghai, China • 1-10 Employees
Company overview
| Headquarters | Shanghai, China |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contacts at Allink Biotherapeutics
Hui Feng
Chief Executive Officer
Jiajia Pan
Associate Director
Li 李
Co-Founder Head Of Research
About Allink Biotherapeutics
Founded in 2023 and based in Shanghai, China, Allink Biotherapeutics is a biotech company dedicated to expediting the development of a diverse pipeline of FIC/BIC therapeutic candidates for oncology and immune diseases. Our goal is to harness our proprietary bispecific antibody and ADC technology platforms, along with efficient execution and business collaboration to address critical unmet clinical needs.
Allink Biotherapeutics revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | $42,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Allink Biotherapeutics has 3 employees across 3 departments.
Departments
Number of employees
Allink Biotherapeutics Tech Stack
Discover the technologies and tools that power Allink Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Security
Frequently asked questions
4.8
40,000 users



